Photo by nci from unsplash
After N-nitrosodimethylamine, a potential carcinogen, was detected in valsartan supplied by Zhejiang Huahai Pharmaceuticals (Zhejiang, China), Health Canada issued a voluntary recall notice on July 9, 2018, for 28 generic… Click to show full abstract
After N-nitrosodimethylamine, a potential carcinogen, was detected in valsartan supplied by Zhejiang Huahai Pharmaceuticals (Zhejiang, China), Health Canada issued a voluntary recall notice on July 9, 2018, for 28 generic valsartan preparations ([1][1]). The impact of drug recalls on health services
Keywords:
impact generic;
generic valsartan;
recall;
recall alberta;
alberta canada;
valsartan recall
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!